Lupin partners with AbbVie to develop, commercialise novel oncology drug

Additionally, Lupin will be entitled to receive a double-digit royalty on the sales of the product and will retain commercial rights to the programme in India, the company added.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news